688163 赛伦生物
已收盘 12-27 15:00:01
资讯
新帖
简况
赛伦生物：公司高度重视投资者关系管理工作，将努力提升与投资者沟通的质量和效率
证券之星 · 12-18
赛伦生物：公司高度重视投资者关系管理工作，将努力提升与投资者沟通的质量和效率
赛伦生物跌5% 主力净流出
智选洞察 · 12-13
赛伦生物跌5% 主力净流出
赛伦生物大涨 主力净流入增加
智选洞察 · 12-12
赛伦生物大涨 主力净流入增加
赛伦生物跌5% 主力净流出
智选洞察 · 12-04
赛伦生物跌5% 主力净流出
赛伦生物（688163）12月3日主力资金净卖出380.84万元
证券之星 · 12-04
赛伦生物（688163）12月3日主力资金净卖出380.84万元
A股创新药板块震荡走高，前沿生物、海南海药此前涨停，百利天恒涨超9%，赛伦生物、康辰药业走高。
美港电讯 · 12-02
A股创新药板块震荡走高，前沿生物、海南海药此前涨停，百利天恒涨超9%，赛伦生物、康辰药业走高。
赛伦生物大涨 广州医药产业获支持
智选洞察 · 12-02
赛伦生物大涨 广州医药产业获支持
赛伦生物：目前，公司主要面向生物毒素中毒临床诊疗需求，研发紧急预防、治疗以及快速诊断产品
每日经济新闻 · 12-01
赛伦生物：目前，公司主要面向生物毒素中毒临床诊疗需求，研发紧急预防、治疗以及快速诊断产品
赛伦生物：公司主营产品为抗血清抗毒素（属于被动免疫制剂），未布局疫苗产品（属于主动免疫制剂）
证券之星 · 11-29
赛伦生物：公司主营产品为抗血清抗毒素（属于被动免疫制剂），未布局疫苗产品（属于主动免疫制剂）
1-10月医保统筹收入稳增长，机构：医药后市反转源于三大机会
汇添富基金 · 11-28
1-10月医保统筹收入稳增长，机构：医药后市反转源于三大机会
赛伦生物冲破20元 主力小幅流出
智选洞察 · 11-26
赛伦生物冲破20元 主力小幅流出
赛伦生物：计提长期股权投资减值准备1414.48万元
每日经济新闻 · 11-22
赛伦生物：计提长期股权投资减值准备1414.48万元
赛伦生物(688163.SH)：暂停安美木单抗临床研究 计提长期股权投资减值1414.48万元
智通财经 · 11-22
赛伦生物(688163.SH)：暂停安美木单抗临床研究 计提长期股权投资减值1414.48万元
赛伦生物跌5% 主力净流出
智选洞察 · 11-22
赛伦生物跌5% 主力净流出
赛伦生物：截至目前，我司与上市公司斯莱克无关联关系，无业务往来
证券之星 · 11-21
赛伦生物：截至目前，我司与上市公司斯莱克无关联关系，无业务往来
赛伦生物大涨 论坛聚焦医药
智选洞察 · 11-21
赛伦生物大涨 论坛聚焦医药
赛伦生物涨5% 生物医药论坛召开
智选洞察 · 11-20
赛伦生物涨5% 生物医药论坛召开
赛伦生物11月18日遭主力抛售365万元 环比增加137.01%
市场透视 · 11-18
赛伦生物11月18日遭主力抛售365万元 环比增加137.01%
赛伦生物大跌5.12% 主力资金净流出24万元
智选洞察 · 11-15
赛伦生物大跌5.12% 主力资金净流出24万元
赛伦生物：公司在研项目抗蝰蛇毒血清目前处于Ⅱ期临床研究阶段，抗蜂毒血清项目处于临床前研究阶段
证券之星 · 11-13
赛伦生物：公司在研项目抗蝰蛇毒血清目前处于Ⅱ期临床研究阶段，抗蜂毒血清项目处于临床前研究阶段
加载更多
公司概况
公司名称：
上海赛伦生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2022-03-11
主营业务：
上海赛伦生物技术股份有限公司成立于1999年，是一家专注于抗血清抗毒素领域的生物医药企业，致力于研究、开发、生产及销售针对生物毒素及生物安全领域的预防和治疗药物。公司的主要产品为抗蛇毒血清、抗狂犬病血清、马破免疫球蛋白。公司的核心技术服务于公司抗血清产品的研发和产业化，已获得GMP认证，并通过韩国MFDS（韩国卫生福利部下属的食品药品安全部）的KGMP（韩国食品药品质量体系认证）现场检查。
发行价格：
33.03
{"stockData":{"symbol":"688163","market":"SH","secType":"STK","nameCN":"赛伦生物","latestPrice":17.96,"timestamp":1735282801000,"preClose":17.93,"halted":0,"volume":723172,"delay":0,"changeRate":0.0017,"floatShares":44372000,"shares":108000000,"eps":0.4706,"marketStatus":"已收盘","change":0.03,"latestTime":"12-27 15:00:01","open":18,"high":18.37,"low":17.68,"amount":13061600,"amplitude":0.0385,"askPrice":18.01,"askSize":17,"bidPrice":17.96,"bidSize":10,"shortable":0,"etf":0,"ttmEps":0.4706,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735522200000},"marketStatusCode":5,"adr":0,"adjPreClose":17.93,"symbolType":"stock_kcb","openAndCloseTimeList":[[1735263000000,1735270200000],[1735275600000,1735282800000]],"highLimit":19.72,"lowLimit":16.14,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":108220000,"isCdr":false,"pbRate":1.74,"roa":"--","peRate":38.164046,"roe":"5.69%","epsLYR":0.36,"committee":-0.365385,"marketValue":1944000000,"turnoverRate":0.0163,"status":0,"afterMarket":{"amount":0,"volume":0,"close":17.96,"buyVolume":0,"sellVolume":0,"time":1735284838975,"indexStatus":"已收盘 12-27 15:30:00","preClose":17.93},"floatMarketCap":797000000},"requestUrl":"/m/hq/s/688163","defaultTab":"news","newsList":[{"id":"2492909772","title":"赛伦生物：公司高度重视投资者关系管理工作，将努力提升与投资者沟通的质量和效率","url":"https://stock-news.laohu8.com/highlight/detail?id=2492909772","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492909772?lang=zh_cn&edition=full","pubTime":"2024-12-18 19:00","pubTimestamp":1734519643,"startTime":"0","endTime":"0","summary":"证券之星消息，赛伦生物12月18日在投资者关系平台上答复投资者关心的问题。公司高度重视投资者关系管理工作，将努力提升与投资者沟通的质量和效率。二级市场股价表现受到多方面因素影响，敬请投资者理性看待股价波动并注意投资风险。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800032944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2491391301","title":"赛伦生物跌5% 主力净流出","url":"https://stock-news.laohu8.com/highlight/detail?id=2491391301","media":"智选洞察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491391301?lang=zh_cn&edition=full","pubTime":"2024-12-13 14:51","pubTimestamp":1734072677,"startTime":"0","endTime":"0","summary":"12月13日，赛伦生物股价大幅下跌，截至14点51分，赛伦生物下跌5.09%，报20.33元/股，成交5307万元，换手率5.76%，振幅5.09%。资金动向截止发稿，赛伦生物获得主力净流出510万元，其中超大单流出358万元，大单流出151万元。融资融券方面，赛伦生物12月12日获得融资净买入286万元，当日该股融资余额为4444万元，当较前一日增加6.89%。最新财报显示，今年三季报，赛伦生物实现营业收入1.73亿元，同比增长4.31%，净利润为6,294.75万元，同比增长23.92%，基本每股收益为0.58元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213145128a1eb3318&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213145128a1eb3318&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688163"],"gpt_icon":0},{"id":"2491334641","title":"赛伦生物大涨 主力净流入增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2491334641","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491334641?lang=zh_cn&edition=full","pubTime":"2024-12-12 10:20","pubTimestamp":1733970006,"startTime":"0","endTime":"0","summary":"资金动向截止发稿，赛伦生物获得主力净流入255万元，其中超大单流入299万元，大单流出43万元。融资融券方面，赛伦生物12月10日获得融资净买入32万元，当日该股融资余额为4171万元，当较前一日增加0.79%，实现2连增。最新财报显示，今年三季报，赛伦生物实现营业收入1.73亿元，同比增长4.31%，净利润为6,294.75万元，同比增长23.92%，基本每股收益为0.58元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121210202395e9163a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121210202395e9163a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688163"],"gpt_icon":0},{"id":"2488532851","title":"赛伦生物跌5% 主力净流出","url":"https://stock-news.laohu8.com/highlight/detail?id=2488532851","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488532851?lang=zh_cn&edition=full","pubTime":"2024-12-04 14:18","pubTimestamp":1733293083,"startTime":"0","endTime":"0","summary":"12月04日，赛伦生物股价大幅下跌，截至14点18分，赛伦生物下跌5.01%，报20.66元/股，成交5106万元，换手率5.47%。资金动向截止发稿，赛伦生物获得主力净流出980万元，其中超大单流出576万元，大单流出402万元。融资融券方面，赛伦生物12月02日获得融资净买入760万元，当日该股融资余额为5137万元，当较前一日增加17.37%。最新财报显示，今年三季报，赛伦生物实现营业收入1.73亿元，同比增长4.31%，净利润为6,294.75万元，同比增长23.92%，基本每股收益为0.58元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204141815971b8946&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204141815971b8946&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688163"],"gpt_icon":0},{"id":"2488909193","title":"赛伦生物（688163）12月3日主力资金净卖出380.84万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488909193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488909193?lang=zh_cn&edition=full","pubTime":"2024-12-04 08:20","pubTimestamp":1733271628,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月3日收盘，赛伦生物报收于21.75元，下跌3.76%，换手率10.79%，成交量4.79万手，成交额1.05亿元。近5日资金流向一览见下表：赛伦生物融资融券信息显示，融资方面，当日融资买入1147.98万元，融资偿还1568.69万元，融资净偿还420.71万元。赛伦生物主营业务：研究、开发、生产及销售针对生物毒素及生物安全领域的预防和治疗药物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120400008402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2488649591","title":"A股创新药板块震荡走高，前沿生物、海南海药此前涨停，百利天恒涨超9%，赛伦生物、康辰药业走高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2488649591","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488649591?lang=zh_cn&edition=full","pubTime":"2024-12-02 13:54","pubTimestamp":1733118886,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1574","603590","688163","688506","BK0188","06978","BK0146","688221","000566","BK0070","BK0239","BK1161","159982","BK0060","399300","159992"],"gpt_icon":0},{"id":"2488644206","title":"赛伦生物大涨 广州医药产业获支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2488644206","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488644206?lang=zh_cn&edition=full","pubTime":"2024-12-02 13:29","pubTimestamp":1733117350,"startTime":"0","endTime":"0","summary":"12月02日，赛伦生物股价大幅上涨，截至13点29分，赛伦生物上涨5.07%，报21.96元/股，创近1个月新高，成交5795万元，换手率6.06%。资金动向截止发稿，赛伦生物获得主力净流出714万元，其中超大单流出266万元，大单流出446万元。最新财报显示，今年三季报，赛伦生物实现营业收入1.73亿元，同比增长4.31%，净利润为6,294.75万元，同比增长23.92%，基本每股收益为0.58元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202132924a2655b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202132924a2655b3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2488368477","title":"赛伦生物：目前，公司主要面向生物毒素中毒临床诊疗需求，研发紧急预防、治疗以及快速诊断产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2488368477","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488368477?lang=zh_cn&edition=full","pubTime":"2024-12-01 07:29","pubTimestamp":1733009371,"startTime":"0","endTime":"0","summary":"赛伦生物11月29日在投资者互动平台表示，公司主营产品为抗血清抗毒素，未布局疫苗产品。公司研发项目后续进程请关注公司公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241201072952a2627bb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241201072952a2627bb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2487538603","title":"赛伦生物：公司主营产品为抗血清抗毒素（属于被动免疫制剂），未布局疫苗产品（属于主动免疫制剂）","url":"https://stock-news.laohu8.com/highlight/detail?id=2487538603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487538603?lang=zh_cn&edition=full","pubTime":"2024-11-29 17:00","pubTimestamp":1732870828,"startTime":"0","endTime":"0","summary":"证券之星消息，赛伦生物11月29日在投资者关系平台上答复投资者关心的问题。公司主营产品为抗血清抗毒素，未布局疫苗产品。目前，公司主要面向生物毒素中毒临床诊疗需求，研发紧急预防、治疗以及快速诊断产品。截至目前公司股东不存在违规减持股份的情形。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112900025224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239","159646"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长，机构：医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上，据医保局日前披露，2024年1-10月医保统筹基金收入23065.07亿元，同比增长8.9%；2024年1-10月统筹支出19165.88亿元，同比增长8.9%。对此，国泰君安表示，1-10月医保统筹基金运行平稳，收入稳健增长，支出增速逐月收窄。国金证券表示，由于多方面因素，医药板块景气度在2021年后经历了长时间的下行。2024年11月7日，国家医保局召开了座谈会，强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600436","688062","603108","600161","688520","688626","688176","688488","688373","688067","600763","688278","688443","688658","600572","600521","600851","688656","159938","688163","688202","688276","688617","600332","605199","600976","688198","688566","600535","688247","688105","600721","600998","BK0012","603233","688189","605177","600211","603939","688177","600351","688271","601607","600566","603392","688389","688085","688114","688690","688578","688581","688192","603439","688166","603658","603456","688137","600529","603367","603882","603309","600085","688506","600511","600062","603590","688298","BK0096","688767","688356","688046","BK0185","600056","688351","688117","600252","688222","688050","603707","600196","BK0028","600329","600867","688315","688321","600380","603858","600420","688331","600276","BK0239","688091","603567","600285","688575","600422","688235","688301","603259","688266","688670","688076","688029","600079","BK0070","BK0188","603896","688687","600488","688193","603087","688221","603538","600055","688212","688382","688180","600129","688428","688161","688073","600771","688139","600739","603301","688336","600080","600200","603127"],"gpt_icon":0},{"id":"2486501327","title":"赛伦生物冲破20元 主力小幅流出","url":"https://stock-news.laohu8.com/highlight/detail?id=2486501327","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486501327?lang=zh_cn&edition=full","pubTime":"2024-11-26 11:06","pubTimestamp":1732590379,"startTime":"0","endTime":"0","summary":"11月26日，赛伦生物股价大幅上涨，截至11点06分，赛伦生物上涨5.08%，报20.28元/股，突破20元整数关口，成交2672万元，换手率3.06%，振幅5.44%。资金动向截止发稿，赛伦生物获得主力净流出22万元，其中超大单流入46万元，大单流出67万元。最新财报显示，今年三季报，赛伦生物实现营业收入1.73亿元，同比增长4.31%，净利润为6,294.75万元，同比增长23.92%，基本每股收益为0.58元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126110633abdf6529&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126110633abdf6529&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2485233945","title":"赛伦生物：计提长期股权投资减值准备1414.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485233945","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485233945?lang=zh_cn&edition=full","pubTime":"2024-11-22 16:24","pubTimestamp":1732263859,"startTime":"0","endTime":"0","summary":"公司严格遵循计提规则，对计提的长期股权投资减值准备，在后续会计期间不得转回。2023年1至12月份，赛伦生物的营业收入构成为：生物医药行业占比100.0%。赛伦生物的董事长是范志和，男，64岁，学历背景为硕士；总经理是范铁炯，男，39岁，学历背景为博士。截至发稿，赛伦生物市值为20亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122162535a24d6a43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122162535a24d6a43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688163"],"gpt_icon":0},{"id":"2485233310","title":"赛伦生物(688163.SH)：暂停安美木单抗临床研究 计提长期股权投资减值1414.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485233310","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485233310?lang=zh_cn&edition=full","pubTime":"2024-11-22 16:17","pubTimestamp":1732263455,"startTime":"0","endTime":"0","summary":"智通财经APP讯，赛伦生物 发布公告，公司的联营企业上海赛远生物科技有限公司决定暂停“安美木单抗”项目的临床研究工作。根据2024年10月31日公司合并财务报表初步测算，公司将在相应资产负债表日对赛远生物的长期股权投资全额计提减值准备及确认投资损失预计金额为1414.48万元，计提后该项长期股权投资账面余额为零。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214563.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688163"],"gpt_icon":0},{"id":"2485283739","title":"赛伦生物跌5% 主力净流出","url":"https://stock-news.laohu8.com/highlight/detail?id=2485283739","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485283739?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:06","pubTimestamp":1732255586,"startTime":"0","endTime":"0","summary":"11月22日，赛伦生物股价大幅下跌，截至14点06分，赛伦生物下跌5.04%，报19.04元/股，失守20元整数关口，成交2866万元，换手率3.30%，振幅5.64%。资金动向截止发稿，赛伦生物获得主力净流出477万元，其中超大单流出184万元，大单流出292万元。最新财报显示，今年三季报，赛伦生物实现营业收入1.73亿元，同比增长4.31%，净利润为6,294.75万元，同比增长23.92%，基本每股收益为0.58元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122140639a24d19a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122140639a24d19a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2485675574","title":"赛伦生物：截至目前，我司与上市公司斯莱克无关联关系，无业务往来","url":"https://stock-news.laohu8.com/highlight/detail?id=2485675574","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485675574?lang=zh_cn&edition=full","pubTime":"2024-11-21 20:00","pubTimestamp":1732190423,"startTime":"0","endTime":"0","summary":"证券之星消息，赛伦生物11月21日在投资者关系平台上答复投资者关心的问题。公司未来如申请回购增持贷款或有回购股份计划，将依据相关法律法规及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100032877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0130","BK0132","688163","BK0028","300382","BK0239","BK0251"],"gpt_icon":0},{"id":"2485410726","title":"赛伦生物大涨 论坛聚焦医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2485410726","media":"智选洞察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485410726?lang=zh_cn&edition=full","pubTime":"2024-11-21 09:36","pubTimestamp":1732153004,"startTime":"0","endTime":"0","summary":"11月21日，赛伦生物股价大幅上涨，截至09点36分，赛伦生物上涨5.02%，报20.93元/股，突破20元整数关口，成交698万元，换手率0.77%，振幅4.92%。资金动向截止发稿，赛伦生物获得主力净流入31万元。融资融券方面，赛伦生物11月19日获得融资净买入11万元，当日该股融资余额为4169万元，当较前一日增加0.34%，实现3连增。主营业务及业绩赛伦生物公司主营业务为研究、开发、生产及销售针对生物毒素及生物安全领域的预防和治疗药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121093707a249f0fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121093707a249f0fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","688163","BK0239"],"gpt_icon":0},{"id":"2484131311","title":"赛伦生物涨5% 生物医药论坛召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2484131311","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484131311?lang=zh_cn&edition=full","pubTime":"2024-11-20 11:24","pubTimestamp":1732073048,"startTime":"0","endTime":"0","summary":"11月20日，赛伦生物股价大幅上涨，截至11点24分，赛伦生物上涨5.05%，报20.19元/股，突破20元整数关口，成交2227万元，换手率2.53%。资金动向截止发稿，赛伦生物获得主力净流入52万元。融资融券方面，赛伦生物11月18日获得融资净买入53万元，当日该股融资余额为4154万元，当较前一日增加1.30%，实现2连增。主营业务及业绩赛伦生物公司主营业务为研究、开发、生产及销售针对生物毒素及生物安全领域的预防和治疗药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120112514abd0d93c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120112514abd0d93c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","399441","161726","688163"],"gpt_icon":0},{"id":"2484614781","title":"赛伦生物11月18日遭主力抛售365万元 环比增加137.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484614781","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484614781?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:21","pubTimestamp":1731914470,"startTime":"0","endTime":"0","summary":"11月18日, 赛伦生物股价跌2.50%，报收18.73元，成交金额3200万元，换手率3.80%，振幅4.89%，量比0.65。赛伦生物今日主力资金净流出365万元，上一交易日主力净流出154万元，今日环比增加137.01%。该股近5个交易日下跌11.53%，主力资金累计净流出1241万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出5849万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118154522a2423573&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118154522a2423573&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2483155513","title":"赛伦生物大跌5.12% 主力资金净流出24万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483155513","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483155513?lang=zh_cn&edition=full","pubTime":"2024-11-15 14:07","pubTimestamp":1731650842,"startTime":"0","endTime":"0","summary":"11月15日，赛伦生物股价大幅下跌，截至14点07分，赛伦生物下跌5.12%，报19.46元/股，失守20元整数关口，成交3621万元，换手率4.07%。资金动向截止发稿，赛伦生物获得主力净流出24万元，其中超大单流出115万元，大单流入92万元。数据显示，该股今日净流入较近5日净流入均值增加208万元。最新财报显示，今年三季报，赛伦生物实现营业收入1.73亿元，同比增长4.31%，净利润为6,294.75万元，同比增长23.92%，基本每股收益为0.58元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115140735abc35c5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115140735abc35c5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2483077493","title":"赛伦生物：公司在研项目抗蝰蛇毒血清目前处于Ⅱ期临床研究阶段，抗蜂毒血清项目处于临床前研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2483077493","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483077493?lang=zh_cn&edition=full","pubTime":"2024-11-13 19:00","pubTimestamp":1731495645,"startTime":"0","endTime":"0","summary":"公司基于多年来对于蛇毒毒素的研究积累、技术优势和持续投入，在抗蛇毒血清新药研发、蛇毒快速诊断试剂系列新产品上进行了研发布局，部分项目已处于临床研究阶段。公司在研项目抗蝰蛇毒血清目前处于Ⅱ期临床研究阶段，抗蜂毒血清项目处于临床前研究阶段。眼镜蛇毒快速诊断试剂于今年上半年进入临床试验阶段，蝮蛇毒、五步蛇毒快速诊断试剂尚处于实验室研究阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300030733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-03-11","address":"上海市青浦区华青路1288号","stockEarnings":[{"period":"1week","weight":-0.0562},{"period":"1month","weight":-0.148},{"period":"3month","weight":0.0891},{"period":"6month","weight":0.4911},{"period":"1year","weight":-0.0661},{"period":"ytd","weight":-0.0806}],"companyName":"上海赛伦生物技术股份有限公司","boardCode":"AI0027","perCapita":"6215股","boardName":"医药制造业","registeredCapital":"10822万元","compareEarnings":[{"period":"1week","weight":0.0095},{"period":"1month","weight":0.0273},{"period":"3month","weight":0.1012},{"period":"6month","weight":0.1458},{"period":"1year","weight":0.1508},{"period":"ytd","weight":0.1429}],"survey":" 上海赛伦生物技术股份有限公司成立于1999年，是一家专注于抗血清抗毒素领域的生物医药企业，致力于研究、开发、生产及销售针对生物毒素及生物安全领域的预防和治疗药物。公司的主要产品为抗蛇毒血清、抗狂犬病血清、马破免疫球蛋白。公司的核心技术服务于公司抗血清产品的研发和产业化，已获得GMP认证，并通过韩国MFDS（韩国卫生福利部下属的食品药品安全部）的KGMP（韩国食品药品质量体系认证）现场检查。","serverTime":1735326125742,"listedPrice":33.03,"stockholders":"7139人(较上一季度增加1.85%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"赛伦生物(688163)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供赛伦生物(688163)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"赛伦生物,688163,赛伦生物股票,赛伦生物股票老虎,赛伦生物股票老虎国际,赛伦生物行情,赛伦生物股票行情,赛伦生物股价,赛伦生物股市,赛伦生物股票价格,赛伦生物股票交易,赛伦生物股票购买,赛伦生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"赛伦生物(688163)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供赛伦生物(688163)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}